PA
Profund Advisors Portfolio holdings
AUM
$2.78B
This Quarter Return
+10.14%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.23B
AUM Growth
+$2.23B
(+18%)
Cap. Flow
+$187M
Cap. Flow
% of AUM
8.36%
Top 10 Holdings %
Top 10 Hldgs %
19.36%
Holding
1,755
New
109
Increased
939
Reduced
649
Closed
58
Top Buys
| 1 |
Gilead Sciences
GILD
|
$15.6M |
| 2 |
Amgen
AMGN
|
$11.7M |
| 3 |
AbbVie
ABBV
|
$11M |
| 4 |
CELG
Celgene Corp
CELG
|
$9.48M |
| 5 |
Biogen
BIIB
|
$8.64M |
Top Sells
| 1 |
ARMH
ARM HOLDINGS PLC ADS
ARMH
|
$2.45M |
| 2 |
ABV
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
|
$2.1M |
| 3 |
Baidu
BIDU
|
$1.92M |
| 4 |
Freeport-McMoran
FCX
|
$1.86M |
| 5 |
Bread Financial
BFH
|
$1.81M |
Sector Composition
| 1 | Healthcare | 24.35% |
| 2 | Technology | 12.32% |
| 3 | Financials | 9.33% |
| 4 | Industrials | 8.43% |
| 5 | Consumer Discretionary | 8.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $78.2M | 3.51% | 1,041,206 +207,621 | +25% | +$15.6M |
|
|
2
Amgen
AMGN
$155B
| $58.5M | 2.62% | 512,520 +102,106 | +25% | +$11.7M |
|
|
3
AbbVie
ABBV
$372B
| $52.4M | 2.35% | 992,191 +208,339 | +27% | +$11M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $47.3M | 2.12% | 279,680 +56,111 | +25% | +$9.48M |
|
|
5
Biogen
BIIB
$19.4B
| $44.7M | 2% | 159,865 +30,890 | +24% | +$8.64M |
|
6
Apple
AAPL
$3.45T
| $41.8M | 1.87% | 74,410 +8,360 | +13% | +$4.69M |
|
7
Alphabet (Google) Class C
GOOG
$2.58T
| $33.5M | 1.5% | 29,929 +4,554 | +18% | +$5.1M |
|
8
Exxon Mobil
XOM
$487B
| $27.9M | 1.25% | 275,966 -16,727 | -6% | -$1.69M |
|
9
Microsoft
MSFT
$3.77T
| $25.3M | 1.13% | 675,322 +74,067 | +12% | +$2.77M |
|
10
Amazon
AMZN
$2.44T
| $22.5M | 1.01% | 56,362 +9,013 | +19% | +$3.59M |
|
11
Johnson & Johnson
JNJ
$427B
| $20.2M | 0.91% | 220,565 +13,326 | +6% | +$1.22M |
|
|
ALXN
12
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $17.7M | 0.79% | 133,014 +26,431 | +25% | +$3.52M |
|
13
Chevron
CVX
$324B
| $15.5M | 0.7% | 124,319 -8,823 | -7% | -$1.1M |
|
14
Pfizer
PFE
$141B
| $15.3M | 0.68% | 497,928 +19,888 | +4% | +$609K |
|
15
Regeneron Pharmaceuticals
REGN
$61.5B
| $14.8M | 0.66% | 53,818 +9,844 | +22% | +$2.71M |
|
16
Meta Platforms (Facebook)
META
$1.86T
| $13.3M | 0.6% | 243,325 +75,032 | +45% | +$4.1M |
|
17
Comcast
CMCSA
$125B
| $12M | 0.54% | 231,845 +35,261 | +18% | +$1.83M |
|
18
Vertex Pharmaceuticals
VRTX
$100B
| $11.8M | 0.53% | 158,336 +31,950 | +25% | +$2.37M |
|
19
Intel
INTC
$107B
| $11.5M | 0.51% | 441,225 +34,037 | +8% | +$884K |
|
20
Merck
MRK
$210B
| $11.4M | 0.51% | 227,372 +14,824 | +7% | +$742K |
|
21
eBay
EBAY
$41.4B
| $11.1M | 0.5% | 201,996 +46,559 | +30% | +$2.56M |
|
22
GE Aerospace
GE
$292B
| $10.5M | 0.47% | 376,027 +56,303 | +18% | +$1.58M |
|
23
JPMorgan Chase
JPM
$829B
| $10.4M | 0.47% | 177,604 -22,412 | -11% | -$1.31M |
|
24
Qualcomm
QCOM
$173B
| $10.4M | 0.47% | 139,876 +14,846 | +12% | +$1.1M |
|
25
Booking.com
BKNG
$181B
| $10.3M | 0.46% | 8,877 +1,759 | +25% | +$2.04M |
|